Article

Origins of Ablation of Bradyarrhythmias

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
Average (ratings)
No ratings
Your rating
Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Dear Sir,

In December, Dr Stavrakis and Dr Po published the excellent article “Ganglionated Plexi Ablation: Physiology and Clinical Applications” in AER.1 Despite the outstanding quality, unfortunately the article presents a very small fault.

The authors state that autonomic ablation for the treatment of bradyarrhythmias was proposed by Yao. GP ablation for vasovagal syncope was first introduced by Yao et al., who reported their initial experience on 10 patients with highly symptomatic vasovagal syncope.

In fact, the ablation of bradyarrhythmias was created, proposed and patented by us, 7 years before, having been developed in the 1990s. The first series of 21 patients was published in 2005 in PACE and was patented in the US in 2005 as well (US 2011 0098.699A1 Patent Application Publication Pub. No.: US 2011/0098.699 A1, JC Pachon Mateos, EI Pachon Mateos).

We also developed and patented a system for strict control of vagal denervation for the treatment of bradyarrhythmias.

Considering the high quality and notability of the authors, the article is highly attractive so it is very important to correct this flaw. Relevant publications by our group will provide further information.2,3

References

  1. Stavrakis S, Po S. Ganglionated Plexi Ablation: Physiology and clinical applications. Arrhythm Electrophysiol Rev 2017;6(4):186–90.
    Crossref | PubMed
  2. Pachon JC, Pachon EI, Pachon JC, et al. ‘Cardioneuroablation’ – new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. Europace 2005;7:1–13.
    Crossref | PubMed
  3. Pachon JC, Pachon EI, Cunha Pachon MZ, et al. Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardioneuroablation long-term results. Europace 2011;13:1231–42.
    Crossref | PubMed